跳至主要内容
临床试验/KCT0003919
KCT0003919尚未招募未知

Comparison of Efficacy of zoledronic acid and other therapy on the prevention of subsequent vertebral compression fracture after percutaneous vertebroplasty in patients with high risk for subsequent vertebral compression fracture: prospective comparative analysis between zoledronic acid-treated group and other therapy (risendronate)-treated group

The Catholic University of Korea, Daejeon St. Mary's Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • 1)BMD: T score > -3.7
  • (2)PVP-treated patient for OVCF
  • (3) Patients who meet all of the above criteria will be defined as the high risk group of secondary new compressionl fracture.

排除标准

  • (1) Pathologic fracture: metastatic vertebral fracture, benign or malignant tumor of vertebral body (ex: multiple myeloma)
  • (2) Spinal infection
  • (3) Previous spinal surgery
  • (4) Systemic disease result in osteoporosis (ex: Vitamin D deficiency, Diabetes Mellitus, previous paresis)
  • (5) Patients with multiple compression fracture
  • (6) Patients with atrial fibrillation

研究者

发起方
The Catholic University of Korea, Daejeon St. Mary's Hospital

相似试验

The effect of zoledronic acid treatment on the... | 临床试验